Zoledronic acid reduces osteoporotic fractures and ensures medication compliance for 1 year
- PMID: 20463438
- DOI: 10.3810/pgm.2010.05.2166
Zoledronic acid reduces osteoporotic fractures and ensures medication compliance for 1 year
Comment on
-
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.N Engl J Med. 2007 May 3;356(18):1809-22. doi: 10.1056/NEJMoa067312. N Engl J Med. 2007. PMID: 17476007 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources